Back to Dashboard
INCY · Healthcare

Incyte Corp

USA Healthcare Filing: 2026-06-30
21/100
Smart-money confidence1 of 3 sources positive
Bottom band — money moving out

company insiders are selling

What this band has actually done: stocks scoring 0–25 beat the S&P 500 over the next three months 39.9% of the time, across 100,496 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
44
Congress
No data
Insiders
0
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$24.6B
Industry
Biotechnology
Sector
Healthcare
Exchange
NasdaqGS
About INCYTE CORP

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers JAKAFI for the treatment of myelofibrosis (MF), polycythemia vera, and steroid-refractory acute graft-versus-host disease; ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; MONJUVI/ MINJUVI for the treatment of diffuse large B-cell lymphoma and Follicular Lymphoma; NIKTIMVO for the treatment of chronic graft-versus-host…

Who's behind the signal
Every informed buyer we can see on INCY, across all three feeds.
Hedge funds · 9
D.E. Shaw & Co New position
Citadel Advisors Increased +191%
Dodge & Cox Decreased −2%
+3 more in the full breakdown below ↓
Insiders
Company insiders Selling
Recent sells21
Congressional trades · 6 on record
Disclosures from 2017-09-08 to 2025-05-15
The newest disclosure we hold for this stock is 2025-05-15. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2025-05-15 Robert P. Bresnahan, Jr. · R-PA House Sold $1,001 - $15,000
2023-03-06 Daniel S. Goldman · D-NY House Sold $1,001 - $15,000
2020-12-22 Gilbert Ray Cisneros, Jr. · D-CA House Sold $1,001 - $15,000
2020-09-16 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2018-11-12 Shelley Moore Capito · R-WV Senate Sold $1,001 - $15,000
2017-09-08 Shelley Moore Capito · R-WV Senate Bought $1,001 - $15,000
Not a model pick — but on our radar. INCYTE CORP isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
1
New positions
4
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to INCYTE CORP
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Bearish
Sentiment
0
Buys
21
Sells
Date Insider Title Action Shares Price Value
2026-08-12 CAGNONI PABLO J Insider SELL 10,803 $120.04 $1,296,792
2026-08-05 Mayes Patrick A Insider SELL 2,207 $123.99 $273,646
2026-08-05 CAGNONI PABLO J Insider SELL 10,640 $122.69 $1,305,422
2026-08-03 Mayes Patrick A Insider SELL 6,055 $120.43 $729,204
2026-07-31 Mayes Patrick A Insider SELL 2,293 $119.41 $273,807
2026-07-31 Mayes Patrick A Insider SELL 326 $121.69 $39,671
2026-07-31 Mayes Patrick A Insider SELL 85 $122.19 $10,386
2026-07-31 Mayes Patrick A Insider SELL 1,642 $119.38 $196,022
2026-07-31 Mayes Patrick A Insider SELL 1,643 $119.51 $196,355
2026-07-31 Mayes Patrick A Insider SELL 2,864 $119.40 $341,962
2026-07-31 Mayes Patrick A Insider SELL 4,695 $119.39 $560,536
2026-07-31 Mayes Patrick A Insider SELL 6,171 $119.43 $737,003
2026-07-31 Mayes Patrick A Insider SELL 2,187 $119.47 $261,281
2026-07-31 Mayes Patrick A Insider SELL 5,332 $119.42 $636,747
2026-07-31 Mayes Patrick A Insider SELL 14,661 $119.46 $1,751,403
2026-07-31 CAGNONI PABLO J Insider SELL 15,888 $119.70 $1,901,794
2026-07-16 Issa Mohamed Khairie Insider SELL 1,093 $115.01 $125,706
2026-07-16 Stein Steven H Insider SELL 1,877 $114.73 $215,348
2026-07-15 Stein Steven H Insider SELL 28,237 $113.05 $3,192,193
2026-06-04 Tray Thomas Insider SELL 2,639 $100.00 $263,900
Showing the 20 most recent of 21 buys & sells.
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell INCYTE CORP or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订